Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. May 15, 2019; 11(5): 393-403
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.393
Table 3 Patient and treatment characteristics
CharacteristicsNo. of patients
Age in yr59 (21–88)
Sex ratio, male: female721: 485
Zubrod-ECOG-WHO
01060
1106
240
30
40
50
Preoperative treatment
25 × 2 Gy with capecitabine346
10 × 3 Gy259
None592
Distance from anal verge
≤ 5 cm817
5–10 cm389
Surgery
LAR894
APR303
Hartmann procedure27
No resection7
Diverting stoma after LAR
Yes313
No581
Pathological TNM classification
pT070
pT159
pT2326
pT3661
pT481
pN0687
pN1284
pN2226